These data indicate that adipocyte Gi signaling is essential for maintaining proper blood glucose homeostasis and that drugs able to selectively stimulate Gi signaling in adipocytes may prove useful for the treatment of T2D and related metabolic disorders. Here, GNAI1 is linked to type 2 diabetes mellitus.